The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
Truth is I made a little 40% gain on SPFL between yesterday and today, don’t much feel too comfortable with the company as I think it’s a bit higher risk, read up on this and have read your comments, seems like a solid company in a unique field, awaiting a buy out by a big pharma……….To be honest seems like it will fit in with a bigger pharma as opposed to being a stand alone acompnay………The only issue is I don’t totally understand how take overs with pharma industry work and if I am being unrealistic thinking that the directors will want to sell at a premium of 100% to the price they bought in at……..Also do you know how long the company can keep going assuming the deal does not materialise on time
In here at 8.75,hope its not a spike, need that fabulous RNS on Monday ha ha
Did a dummy sell, offering 2.90 on my small holding right now
Whats the buying pressure like, sorry for the questions
thks
thks
Are there any more compnaies like this with low SP's relative to NAV, amazing whts happening here, OCH and also ATD over the last week
What do u guys expect next two weeks,
Thanks but trying to get head around this, we have a market cap of 5 mill but are also carrying a debt of 5 million, hmm
Why do you say 15p, whts the maths behind that figure
So Therakind don’t have full rights to the drug, interesting, well I do think the drup will be a success just based on the fact that the drug used is administered rectally and this administered orally, I think that’s a great advantage to have and I think this is one of those shares to hold into late next year or beyond, unless they come back and say the payments are so minimal that they wont have much effect on ipso’s SP……
Is anyone familiar with terms in the pharamaceutical industry, or have a rough idea of what Therakind is worth now and what they will be worth when they have received payments due them……..
“This approval has triggered a further milestone payment for Therakind. Therakind is expected to also receive royalties on sales of this product as Viropharma is now able to actively market this product across Europe.” This is wht the RNS says, Therakind will receive payment the amount we don’t know but they will receive payment unless I misunderstand something
Sam I don’t think it will be straight 36% of the royalties/milestone payments, I mean one would expect therakind to cover running costs and re invest for the future and then may decide to pay a dividend its shareholders, now if the dividend is 2 million then ipso gets 36% of the dividend, and there is also the possibility that theriakind may decide not to pay a dividend and re invest proceeds in order to increase shareholder value, which to me in the long run is good for us, I wonder what happens if one buys viropharma becomes the aim of a takeover bid
Is there anyway to find out or does anyone know what Therakind is worth and what type of royalties do you think they will get from Viropharma in terms of the significant payment etc milestone payments……….is it possible that the 36% of Therakind is worth more than the present market share is reflecting, I mean lets say 36% of 10 or 20 or 30 or 40 million, how does that translate to an increase in ipso’s SP……..I want to hold this to late next year, at 1pound a share 38 million mark cap, is that an unreasonable figure
I was thinking about this share and just cant get my head around the market cap being so low, considering they have 36% in Therakind who are about to start selling a drug in Europe, my question is that whats the market cap of Therakind if any one knows and how can this stay at this price is for instance Therakind have revenues of say 100 million(am I being over optimistic), my strategy here is price allows is to try and get to 200k and once it hits the teens will top slice or may not and just hold this for a long time, I see no reason why this share cant trade at its former price of 85p, such few shares in circulation and 36% of X, wht is that X worth in a year or two
If therakind were taken over do u think they might take us over as well
That’s the million dollar question, when is the next RNS, this month, November or are we looking at next year
What kind of timeframes are u looking at and r u aware of this mid October date that was mentioned in the past as when information was due
When are we expecting news from IPSO as to the details on the 36% share they have and how that translates into figures for them